Clinical Trials Directory

Trials / Completed

CompletedNCT00115232

Inflammatory Profiles of Children at High Risk for Atherosclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Boston Children's Hospital · Academic / Other
Sex
All
Age
8 Years – 21 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate levels of inflammatory mediators in children at risk for cardiovascular disease due to family history. We are measuring inflammatory markers in two groups of children and their parents: children with a family history of early atherosclerotic heart disease (cases), and healthy children without such a family history (controls). The design is a cross-sectional study, gathering a fasting blood sample and clinical and behavioral data on children and a parent.

Detailed description

Family history is a well known risk factor for early atherosclerosis. Whether inflammation plays a role in the increased risk of family history is not known. In this prospective single-center study, we are recruiting children with and without a family history of premature atherosclerotic disease, defined as occurring \< 55 years in males and \<65 years in females. Children are recruited primarily from a pediatric preventive cardiology clinic at Children's Hospital Boston. We measure anthropomorphic characteristics, fasting lipid profiles and inflammatory marker levels, including high sensitivity C-reactive protein (hsCRP), intracellular adhesion molecule 1 (ICAM-1), P-selectin, and tumor necrosis factor alpha receptor 2 (TNFαR2). In this sample of high-risk overweight children, Lp(a) and inflammatory markers could reflect cardiovascular risk outside lipid profiles.

Conditions

Timeline

Start date
2004-07-01
Primary completion
2006-10-01
Completion
2007-03-01
First posted
2005-06-22
Last updated
2008-01-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00115232. Inclusion in this directory is not an endorsement.

Inflammatory Profiles of Children at High Risk for Atherosclerosis (NCT00115232) · Clinical Trials Directory